Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Neoplasms 7 Leukemia, Myeloid, Acute 7 Lung Neoplasms 5 Ovarian Neoplasms 4 Fatigue 4 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Lymphoma 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Leukemia 2 Hematologic Neoplasms 2 Glioma 2 Genital Neoplasms, Female 2 Esophageal Neoplasms 2 Depression 2 Weight Loss 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Radiotherapy 11 Cisplatin 11 Radiotherapy, Intensity-Modulated 6 Radiation 5 Fluorouracil 5 Cetuximab 5 pembrolizumab 4 Carboplatin 3 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Vorinostat 2 Surveys and Questionnaires 2 Restraint, Physical 2 Psychiatric Rehabilitation 2 Polymerase Chain Reaction 2 Paclitaxel 2 Nivolumab 2 Nicotine 2 Immunohistochemistry 2 Hydroxyurea 2 Gene Expression Profiling 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Counseling 2 Celecoxib 2 Bupropion 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Oropharyngeal Neoplasms × Palliative Care × Clear all

NCT04952922 2025-08-08

FUNQOLR

Royal Marsden NHS Foundation Trust

25 enrolled 8 charts

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡